Scientists have devised a strategy to target cancer cells while sparing normal cells by capitalizing on vulnerabilities that are exposed only in tumor cells. These vulnerabilities are known as the ‘Achilles heel’ of cancer cells. Although much is known about the mutations that cause a cell to become malignant, little is known about these vulnerabilities.